id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-P-0325-0002,FDA,FDA-2006-P-0325,Acknowledgement Letter from FDA DMB to Vaccine for All LLC,Other,Acknowledgement Letter/Receipt,2006-12-29T05:00:00Z,2006,12,,,2024-12-10T17:14:33Z,,0,0,090000648045ce8c
FDA-2006-N-0100-0018,FDA,FDA-2006-N-0100,National Cancer Institute,Other,TS-Testimony,2006-12-29T05:00:00Z,2006,12,,,2008-04-11T23:09:24Z,,0,0,090000648044504a
FDA-2006-P-0325-0001,FDA,FDA-2006-P-0325,Acknowledgement Letter from FDA DMB to Vaccine for All LLC,Other,Acknowledgement Letter/Receipt,2006-12-29T05:00:00Z,2006,12,,,2024-12-10T17:14:04Z,,0,0,090000648045ce69
FDA-2006-P-0003-0003,FDA,FDA-2006-P-0003,"FDA/OC to CoMed, Coalition for Mercury-Free Drugs",Other,LET-Letter,2006-12-28T05:00:00Z,2006,12,,,2008-04-11T23:16:24Z,,0,0,09000064804413d6
FDA-2006-P-0003-0001,FDA,FDA-2006-P-0003,"FDA/DDM to CoMed, Coalition for Mercury-Free Drugs",Other,ACK-Acknowledgement Letter,2006-12-28T05:00:00Z,2006,12,,,2008-04-11T23:16:24Z,,0,0,09000064804413a7
FDA-2004-P-0001-0007,FDA,FDA-2004-P-0001,FDA/CBER Response to Coalition for Mercury-Free Drugs (CoMeD) - Answer,Other,ANS-Answer,2006-12-28T05:00:00Z,2006,12,,,2009-10-19T19:01:20Z,,0,0,090000648046a67e
FDA-2006-P-0003-0002,FDA,FDA-2006-P-0003,"FDA/DDM to CoMed, Coalition for Mercury-Free Drugs",Other,ACK-Acknowledgement Letter,2006-12-28T05:00:00Z,2006,12,,,2008-04-11T23:16:23Z,,0,0,09000064804413d5
FDA-1996-N-0028-0037,FDA,FDA-1996-N-0028,"FDA Office of Policy to the Docket, 12/26/2006 (re Meeting on September 20, 2006 between the Food and Drug Administration and the Natural Products Association) - Memorandum Meeting",Other,MM-Memorandum of Meeting,2006-12-28T05:00:00Z,2006,12,,,2009-09-11T19:52:51Z,,0,0,09000064804fbfa5
FDA-2006-P-0344-0002,FDA,FDA-2006-P-0344,Acknowledgment Letter from FDA DMB to King & Spalding LLP,Other,Acknowledgement Letter/Receipt,2006-12-27T05:00:00Z,2006,12,,,2024-12-10T15:26:25Z,,0,0,090000648045f14e
FDA-2006-P-0344-0001,FDA,FDA-2006-P-0344,Acknowledgment Letter from FDA DMB to King & Spalding LLP,Other,Acknowledgement Letter/Receipt,2006-12-27T05:00:00Z,2006,12,,,2024-12-10T15:25:34Z,,0,0,090000648045f12b
FDA-2006-P-0146-0002,FDA,FDA-2006-P-0146,"Acknowledgment Letter from FDA DMB to King and Spalding, LLP",Other,Acknowledgement Letter/Receipt,2006-12-27T05:00:00Z,2006,12,,,2024-12-10T16:05:27Z,,0,0,09000064804504bc
FDA-2006-P-0146-0001,FDA,FDA-2006-P-0146,"Acknowledgment Letter from FDA DMB to King and Spalding, LLP",Other,Acknowledgement Letter/Receipt,2006-12-27T05:00:00Z,2006,12,,,2024-12-10T16:01:23Z,,0,0,09000064804504ab
FDA-2006-E-0322-0001,FDA,FDA-2006-E-0322,U.S. Patent and Trademark Office to FDA/CDER (HFD-7),Other,LET-Letter,2006-12-26T05:00:00Z,2006,12,,,2008-04-11T23:07:56Z,,0,0,090000648045cce0
FDA-2005-P-0313-0004,FDA,FDA-2005-P-0313,Petition Denial from FDA CDER to Charles J. Raubicheck,Other,Denial,2006-12-26T05:00:00Z,2006,12,,,2024-12-16T16:54:26Z,,0,0,0900006480447a06
FDA-2006-E-0506-0002,FDA,FDA-2006-E-0506,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-12-26T05:00:00Z,2006,12,,,2026-01-06T20:55:50Z,,0,0,090000648046399d
FDA-2006-E-0506-0001,FDA,FDA-2006-E-0506,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-12-26T05:00:00Z,2006,12,,,2026-01-06T20:53:27Z,,0,0,0900006480463997
FDA-2000-V-0069-0001,FDA,FDA-2000-V-0069,"FDA/CDRH to Level Entertainment, LLC - Approval for Variance",Other,Approval for Variance (VRA),2006-12-26T05:00:00Z,2006,12,,,2025-07-30T17:21:44Z,,0,0,09000064804b00bf
FDA-2006-E-0125-0002,FDA,FDA-2006-E-0125,Request for Certificate of Correction from U.S. Patent and Trademark Office,Other,Letter(s),2006-12-26T05:00:00Z,2006,12,,,2026-01-06T19:13:42Z,,0,0,09000064804501c7
FDA-2005-P-0125-0004,FDA,FDA-2005-P-0125,Petition Denial from FDA CDER to James Salsman,Other,Denial,2006-12-26T05:00:00Z,2006,12,,,2024-12-13T20:25:39Z,,0,0,090000648043fc52
FDA-2006-E-0125-0001,FDA,FDA-2006-E-0125,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-12-26T05:00:00Z,2006,12,,,2026-01-06T19:09:03Z,,0,0,09000064804501bf
FDA-1999-V-0028-0002,FDA,FDA-1999-V-0028,Center for Devices and Radiological Health to John's Laser Productions - Approval for Variance,Other,Approval for Variance (VRA),2006-12-26T05:00:00Z,2006,12,,,2025-04-21T20:30:07Z,,0,0,09000064804a5c96
FDA-1997-S-0006-0227,FDA,FDA-1997-S-0006,FDA/CFSAN to Holistic Therapies,Other,LET-Letter,2006-12-22T05:00:00Z,2006,12,,,2008-05-16T22:07:05Z,,0,0,09000064805c995e
FDA-1997-S-0006-0229,FDA,FDA-1997-S-0006,FDA/CFSAN to Tronex Company,Other,LET-Letter,2006-12-22T05:00:00Z,2006,12,,,2008-05-16T22:07:03Z,,0,0,09000064805c9960
FDA-1997-S-0006-0231,FDA,FDA-1997-S-0006,FDA/CFSAN to Calgenex Corporation,Other,LET-Letter,2006-12-22T05:00:00Z,2006,12,,,2008-05-16T22:07:09Z,,0,0,09000064805c9962
FDA-1997-S-0006-0230,FDA,FDA-1997-S-0006,FDA/CFSAN to Enzymatic Therapy Inc,Other,LET-Letter,2006-12-22T05:00:00Z,2006,12,,,2008-05-16T22:06:57Z,,0,0,09000064805c9961
FDA-1997-S-0006-0228,FDA,FDA-1997-S-0006,FDA/CFSAN to Tronex Company,Other,LET-Letter,2006-12-22T05:00:00Z,2006,12,,,2008-05-16T22:06:55Z,,0,0,09000064805c995f
FDA-1997-S-0006-0226,FDA,FDA-1997-S-0006,FDA/CFSAN to Flora Inc,Other,LET-Letter,2006-12-22T05:00:00Z,2006,12,,,2008-05-16T22:07:01Z,,0,0,09000064805c995d
FDA-1997-S-0006-0232,FDA,FDA-1997-S-0006,FDA/CFSAN to World Nutrition Inc,Other,LET-Letter,2006-12-22T05:00:00Z,2006,12,,,2008-05-16T22:07:09Z,,0,0,09000064805c9963
FDA-1997-S-0006-0225,FDA,FDA-1997-S-0006,FDA/CFSAN to Enzymatic Therapy Inc,Other,LET-Letter,2006-12-22T05:00:00Z,2006,12,,,2008-05-16T22:07:07Z,,0,0,09000064805c995c
FDA-2006-P-0346-0004,FDA,FDA-2006-P-0346,Corrected Acknowledgement Letter to Endo Pharmaceuticals Inc,Other,Correction(s),2006-12-21T05:00:00Z,2006,12,,,2012-04-18T22:53:07Z,,0,0,090000648045f269
FDA-1978-N-0023-0020,FDA,FDA-1978-N-0023,"Memorandum of Telephone Conversation between FDA/CDER and Venable, LLP",Other,Memorandum,2006-12-21T05:00:00Z,2006,12,,,2019-09-16T13:06:41Z,,0,0,090000648055fba3
FDA-2004-P-0278-0004,FDA,FDA-2004-P-0278,Citizen Petition Denial from FDA CFSAN to the Center for Science in the Public Interest (CSPI),Other,PDN-Petition Denial,2006-12-21T05:00:00Z,2006,12,2006-12-15T05:00:00Z,,2025-02-19T16:56:00Z,,0,0,090000648047269b
FDA-2002-P-0246-0001,FDA,FDA-2002-P-0246,Petition Denial from FDA  Associate Commissioner for Regulatory Affairs to Auishalom Klammer,Other,PDN-Petition Denial,2006-12-21T05:00:00Z,2006,12,,,2024-08-15T13:51:59Z,,0,0,090000648049aa59
FDA-2006-N-0543-0019,FDA,FDA-2006-N-0543,FDA to Honorable Richard G. Lugar,Other,LET-Letter,2006-12-20T05:00:00Z,2006,12,,,2008-04-11T23:15:33Z,,0,0,09000064804690aa
FDA-2006-N-0543-0018,FDA,FDA-2006-N-0543,FDA to Honorable John Warner - Letter,Other,LET-Letter,2006-12-20T05:00:00Z,2006,12,,,2009-02-17T23:03:30Z,,0,0,09000064804690a9
FDA-2006-P-0267-0001,FDA,FDA-2006-P-0267,"Acknowledgment Letter from FDA DMB to Emil Tanghetti, MD",Other,Acknowledgement Letter/Receipt,2006-12-20T05:00:00Z,2006,12,,,2025-01-27T14:47:27Z,,0,0,0900006480457d63
FDA-1978-N-0023-0008,FDA,FDA-1978-N-0023,"Internal Memo from Jeffery Shuren, FDA/Office of the Commissioner, to FDA/DDM (HFA-305) dated December 19, 2006",Other,Memorandum,2006-12-20T05:00:00Z,2006,12,,,2019-10-11T16:36:58Z,,0,0,090000648055f84b
FDA-2006-N-0543-0020,FDA,FDA-2006-N-0543,FDA to Kathleen HArner,Other,LET-Letter,2006-12-20T05:00:00Z,2006,12,,,2008-04-11T23:15:42Z,,0,0,09000064804690ab
FDA-2006-N-0543-0017,FDA,FDA-2006-N-0543,FDA to Honorable George Allen - Letter,Other,LET-Letter,2006-12-20T05:00:00Z,2006,12,,,2009-02-17T23:01:37Z,,0,0,09000064804690a8
FDA-2006-N-0543-0016,FDA,FDA-2006-N-0543,FDA to Honorable Evan Bayh,Other,LET-Letter,2006-12-20T05:00:00Z,2006,12,,,2008-04-11T23:15:16Z,,0,0,09000064804690a7
FDA-2006-N-0543-0013,FDA,FDA-2006-N-0543,FDA to Honorable Patty Murray - Letter,Other,LET-Letter,2006-12-20T05:00:00Z,2006,12,,,2009-02-19T21:43:10Z,,0,0,09000064804690a4
FDA-2006-P-0203-0005,FDA,FDA-2006-P-0203,"Interim Response from FDA CDER to Mylan Pharmaceuticals, Inc.",Other,Letter(s),2006-12-20T05:00:00Z,2006,12,,,2024-11-21T13:46:24Z,,0,0,09000064804510d6
FDA-2006-N-0543-0014,FDA,FDA-2006-N-0543,FDA to Kathleen HArner,Other,LET-Letter,2006-12-20T05:00:00Z,2006,12,,,2008-04-11T23:15:42Z,,0,0,09000064804690a5
FDA-2006-N-0543-0015,FDA,FDA-2006-N-0543,FDA to Honorable Rick Santorum,Other,LET-Letter,2006-12-20T05:00:00Z,2006,12,,,2008-04-11T23:15:07Z,,0,0,09000064804690a6
FDA-2006-P-0267-0002,FDA,FDA-2006-P-0267,"Acknowledgment Letter from FDA DMB to Emil Tanghetti, MD",Other,Acknowledgement Letter/Receipt,2006-12-20T05:00:00Z,2006,12,,,2025-01-27T14:48:57Z,,0,0,0900006480457d8d
FDA-2006-P-0025-0002,FDA,FDA-2006-P-0025,FDA/DDM to Sanofi-aventis US LLP,Other,ACK-Acknowledgement Letter,2006-12-19T05:00:00Z,2006,12,,,2008-04-11T23:17:24Z,,0,0,0900006480441f21
FDA-2006-P-0025-0001,FDA,FDA-2006-P-0025,FDA/DDM to Sanofi-aventis US LLP,Other,ACK-Acknowledgement Letter,2006-12-19T05:00:00Z,2006,12,,,2008-04-11T23:17:24Z,,0,0,0900006480441ef8
FDA-2006-P-0334-0004,FDA,FDA-2006-P-0334,Acknowledgment Letter from FDA DMB to Center for Science in the Public Interest,Other,Acknowledgement Letter/Receipt,2006-12-19T05:00:00Z,2006,12,,,2025-01-27T16:14:34Z,,0,0,090000648045d310
FDA-2006-P-0334-0003,FDA,FDA-2006-P-0334,Acknowledgment Letter from FDA DMB to Center for Science in the Public Interest,Other,Acknowledgement Letter/Receipt,2006-12-19T05:00:00Z,2006,12,,,2025-01-27T16:10:25Z,,0,0,090000648045d30f
FDA-2006-P-0387-0003,FDA,FDA-2006-P-0387,FDA Interim Reponse to Orchid Healthcare,Other,LET-Letter,2006-12-18T05:00:00Z,2006,12,,,2009-04-01T16:00:56Z,,0,0,0900006480460607
FDA-2006-V-0221-0001,FDA,FDA-2006-V-0221,FDA/DDM to Mountain High Resort,Other,ACK-Acknowledgement Letter,2006-12-18T05:00:00Z,2006,12,,,2008-04-11T23:22:27Z,,0,0,09000064804520fb
FDA-1995-V-0012-0002,FDA,FDA-1995-V-0012,Laseronics Northwest dba Laseronics Design Interstellar,Other,VRA-Approval for Variance,2006-12-18T05:00:00Z,2006,12,,,2013-08-11T02:44:08Z,,0,0,090000648055847a
FDA-2006-V-0221-0002,FDA,FDA-2006-V-0221,FDA/DDM to Mountain High Resort,Other,ACK-Acknowledgement Letter,2006-12-18T05:00:00Z,2006,12,,,2008-04-11T23:22:27Z,,0,0,090000648045212b
FDA-2000-V-0217-0003,FDA,FDA-2000-V-0217,FDA Center for Devices and Radiological Health to Laser Wizardry - Approval for Variance,Other,VRA-Approval for Variance,2006-12-18T05:00:00Z,2006,12,,,2008-05-06T14:59:45Z,,0,0,09000064804d4fb0
FDA-2006-P-0346-0001,FDA,FDA-2006-P-0346,Acknowledgement Letter to Endo Pharmaceuticals Inc,Other,Acknowledgement Letter/Receipt,2006-12-18T05:00:00Z,2006,12,,,2012-04-18T22:43:25Z,,0,0,090000648045f22c
FDA-2005-P-0366-0004,FDA,FDA-2005-P-0366,Petition Approval from FDA/Associate Commissioner for Policy and Planning to Keller and Heckman LLP,Other,Approval,2006-12-18T05:00:00Z,2006,12,,,2025-04-24T18:45:27Z,,0,0,090000648044af45
FDA-2006-P-0277-0002,FDA,FDA-2006-P-0277,Acknowledgement Letter from FDA DMB to Michael Patterson,Other,,2006-12-18T00:00:00Z,2006,12,,,2025-01-27T15:12:27Z,,0,1,090000648045840f
FDA-2006-V-0098-0005,FDA,FDA-2006-V-0098,N9NE Group dba Moon Bar - Approval for a Variance,Other,VRA-Approval for Variance,2006-12-15T05:00:00Z,2006,12,,,2008-09-09T12:57:35Z,,0,0,0900006480444cfb
FDA-2006-E-0197-0001,FDA,FDA-2006-E-0197,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-12-15T05:00:00Z,2006,12,,,2025-12-19T00:01:54Z,,0,0,0900006480450eec
FDA-2006-P-0010-0003,FDA,FDA-2006-P-0010,Interim Response from FDA CVM to Sidley Austin LLP,Other,Letter(s),2006-12-15T05:00:00Z,2006,12,,,2024-10-28T17:16:53Z,,0,0,090000648044158b
FDA-1978-N-0018-0493,FDA,FDA-1978-N-0018,Letter from FDA/CDER to Schering-Plough Consumer Healthcare,Other,Letter(s),2006-12-15T05:00:00Z,2006,12,,,2019-08-02T16:36:22Z,,0,0,090000648055aa60
FDA-2006-V-0098-0006,FDA,FDA-2006-V-0098,FDA/CDRH to N9NE Group dba Moon Bar - Variance Attachment B,Other,VRA-Approval for Variance,2006-12-15T05:00:00Z,2006,12,,,2008-09-09T14:09:39Z,,0,0,0900006480444cfd
FDA-2006-E-0197-0002,FDA,FDA-2006-E-0197,Notice of Informalities from U.S. Patent and Trademark Office to Bristol-Myers Squibb Company,Other,Letter(s),2006-12-15T05:00:00Z,2006,12,,,2025-12-19T00:04:01Z,,0,0,0900006480450ef7
FDA-2006-P-0404-0002,FDA,FDA-2006-P-0404,FDA/CFSAN to Hyman Phelps & McNamara PC,Other,LET-Letter,2006-12-15T05:00:00Z,2006,12,,,2008-04-11T23:21:26Z,,0,0,0900006480460d51
FDA-2006-V-0098-0004,FDA,FDA-2006-V-0098,N9NE Group dba Moon Bar - Variance Attachment A,Other,VRA-Approval for Variance,2006-12-15T05:00:00Z,2006,12,,,2008-09-09T14:20:13Z,,0,0,0900006480444cf8
FDA-2001-V-0064-0001,FDA,FDA-2001-V-0064,FDA/CDRH Response to Nth Degree Creative - Approval for Variance,Other,VRA-Approval for Variance,2006-12-15T05:00:00Z,2006,12,,,2009-05-23T00:49:19Z,,0,0,09000064804b8141
FDA-1999-E-0123-0001,FDA,FDA-1999-E-0123,Letter from FDA/CDER to the USPTO,Other,Letter(s),2006-12-15T00:00:00Z,2006,12,,,2025-05-14T15:34:58Z,,0,0,09000064804ae996
FDA-2006-N-0107-0003,FDA,FDA-2006-N-0107,Duplicate,Other,LST-List,2006-12-14T05:00:00Z,2006,12,,,2008-11-18T22:36:08Z,,0,0,090000648044f71c
FDA-2006-N-0107-0005,FDA,FDA-2006-N-0107,Duplicate,Other,LST-List,2006-12-14T05:00:00Z,2006,12,,,2008-11-18T22:40:24Z,,0,0,090000648044f720
FDA-2006-P-0214-0001,FDA,FDA-2006-P-0214,"Acknowledgment Letter from FDA DMB to Kleinfeld, Kaplan and Becker, LLP",Other,Acknowledgement Letter/Receipt,2006-12-14T05:00:00Z,2006,12,,,2024-12-09T14:30:53Z,,0,0,0900006480451d15
FDA-2006-P-0214-0002,FDA,FDA-2006-P-0214,"Acknowledgment Letter from FDA DMB to Kleinfeld, Kaplan and Becker, LLP",Other,Acknowledgement Letter/Receipt,2006-12-14T05:00:00Z,2006,12,,,2024-12-09T14:34:53Z,,0,0,0900006480451d47
FDA-2006-P-0271-0001,FDA,FDA-2006-P-0271,"Acknowledgment Letter from FDA DMB to Caraco Pharmaceutical Laboratories, Ltd.",Other,Acknowledgement Letter/Receipt,2006-12-14T05:00:00Z,2006,12,,,2025-01-27T15:43:34Z,,0,0,090000648045806e
FDA-2006-P-0271-0002,FDA,FDA-2006-P-0271,"Acknowledgment Letter from FDA DMB to Caraco Pharmaceutical Laboratories, Ltd.",Other,Acknowledgement Letter/Receipt,2006-12-14T05:00:00Z,2006,12,,,2025-01-27T15:49:44Z,,0,0,0900006480458073
FDA-2006-N-0107-0002,FDA,FDA-2006-N-0107,Panelists for the Part 15 Public Hearing,Other,LST-List,2006-12-14T05:00:00Z,2006,12,,,2013-07-27T20:43:43Z,,0,0,090000648044f71a
FDA-2006-N-0107-0004,FDA,FDA-2006-N-0107,Part 15 Public Hearing Schedule,Other,LST-List,2006-12-14T05:00:00Z,2006,12,,,2013-07-27T20:43:43Z,,0,0,090000648044f71e
FDA-1990-S-0006-0159,FDA,FDA-1990-S-0006,Statistical Report - Month of November 2006,Other,RPT-Report (outside of agency unless indicated),2006-12-14T05:00:00Z,2006,12,,,2008-05-16T23:51:58Z,,0,0,09000064805260fa
FDA-2006-P-0068-0003,FDA,FDA-2006-P-0068,"Letter from FDA CDER to Schwarz Pharma, Inc.",Other,Letter(s),2006-12-14T05:00:00Z,2006,12,,,2024-12-05T16:13:42Z,,0,0,0900006480444446
FDA-2006-P-0145-0002,FDA,FDA-2006-P-0145,"Acknowledgement Letter FDA DMB to Lachman Consultant Services, Inc.",Other,Acknowledgement Letter/Receipt,2006-12-14T05:00:00Z,2006,12,,,2024-12-10T13:39:51Z,,0,0,090000648045049f
FDA-2006-P-0073-0003,FDA,FDA-2006-P-0073,"Letter from FDA CDER to AstraZeneca, LP [Ropes & Gray]",Other,Letter(s),2006-12-12T05:00:00Z,2006,12,,,2024-10-28T14:00:51Z,,0,0,0900006480444589
FDA-2006-E-0320-0002,FDA,FDA-2006-E-0320,Letter from FDA CDER to U.S. Patent and Trademark Offce,Other,Letter(s),2006-12-12T05:00:00Z,2006,12,,,2025-12-19T23:18:55Z,,0,0,090000648045cc28
FDA-2006-V-0463-0002,FDA,FDA-2006-V-0463,FDA / DDM to LFI International,Other,ACK-Acknowledgement Letter,2006-12-12T05:00:00Z,2006,12,,,2008-04-11T23:22:43Z,,0,0,0900006480462955
FDA-2006-P-0449-0002,FDA,FDA-2006-P-0449,Acknowledgment Letter from FDA DMB to Charles E. Weber,Other,Acknowledgement Letter/Receipt,2006-12-12T05:00:00Z,2006,12,,,2024-12-09T17:25:32Z,,0,0,0900006480462236
FDA-2006-P-0449-0001,FDA,FDA-2006-P-0449,Acknowledgment Letter from FDA DMB to Charles E. Weber,Other,Acknowledgement Letter/Receipt,2006-12-12T05:00:00Z,2006,12,,,2024-12-10T02:01:04Z,,0,0,0900006480462219
FDA-2006-V-0463-0001,FDA,FDA-2006-V-0463,FDA / DDM to LFI International,Other,ACK-Acknowledgement Letter,2006-12-12T05:00:00Z,2006,12,,,2008-04-11T23:22:43Z,,0,0,090000648046294c
FDA-2006-E-0439-0003,FDA,FDA-2006-E-0439,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-12-12T05:00:00Z,2006,12,,,2026-01-08T00:50:31Z,,0,0,0900006480461ec1
FDA-2006-P-0017-0003,FDA,FDA-2006-P-0017,Interim Response Letter from FDA CFSAN to Yoon Ja Kim,Other,,2006-12-12T00:00:00Z,2006,12,,,2025-01-30T17:47:15Z,,0,1,09000064804416e3
FDA-2006-P-0077-0002,FDA,FDA-2006-P-0077,"Acknowledgment Letter from FDA DMB to Sicor Pharmaceuticals, Inc.",Other,Acknowledgement Letter/Receipt,2006-12-11T05:00:00Z,2006,12,,,2024-12-10T14:56:54Z,,0,0,090000648044470e
FDA-2006-P-0334-0001,FDA,FDA-2006-P-0334,Acknowledgment Letter from FDA DMB to Center for Science in the Public Interest,Other,Acknowledgement Letter/Receipt,2006-12-11T05:00:00Z,2006,12,,,2025-01-27T16:06:30Z,,0,0,090000648045d2e9
FDA-2006-P-0334-0002,FDA,FDA-2006-P-0334,Acknowledgment Letter from FDA DMB to Center for Science in the Public Interest,Other,Acknowledgement Letter/Receipt,2006-12-11T05:00:00Z,2006,12,,,2025-01-27T16:08:20Z,,0,0,090000648045d30d
FDA-2006-P-0077-0001,FDA,FDA-2006-P-0077,"Acknowledgment Letter from FDA DMB to Sicor Pharmaceuticals, Inc.",Other,Acknowledgement Letter/Receipt,2006-12-11T05:00:00Z,2006,12,,,2024-12-10T14:55:59Z,,0,0,0900006480444704
FDA-1980-N-0074-0082,FDA,FDA-1980-N-0074,FDA/ORA to Colgate-Palmolive Company,Other,PDN-Petition Denial,2006-12-11T05:00:00Z,2006,12,,,2008-05-30T22:52:54Z,,0,0,09000064805bb550
FDA-2006-P-0399-0002,FDA,FDA-2006-P-0399,"Acknowledgment Letter from FDA CDER to Lachman Consultant Services, Inc",Other,Acknowledgement Letter/Receipt,2006-12-08T05:00:00Z,2006,12,,,2024-11-25T16:29:15Z,,0,0,0900006480460afb
FDA-2006-P-0404-0001,FDA,FDA-2006-P-0404,"FDA/CFSAN to Hyman, Phelps & McNamara PC for Cargill",Other,ACK-Acknowledgement Letter,2006-12-08T05:00:00Z,2006,12,,,2008-04-11T23:21:26Z,,0,0,0900006480460d23
FDA-1976-N-0027-0030,FDA,FDA-1976-N-0027,"Memorandum of Teleconference Between  FDA/CDER and Walter N. Kernan, M.D. Yale University School of Medicine",Other,Memorandum,2006-12-08T05:00:00Z,2006,12,,,2015-12-14T21:39:42Z,,0,0,090000648051b8e7
FDA-2006-P-0399-0001,FDA,FDA-2006-P-0399,"Acknowledgment Letter from FDA CDER to Lachman Consultant Services, Inc",Other,Acknowledgement Letter/Receipt,2006-12-08T05:00:00Z,2006,12,,,2024-11-25T16:28:06Z,,0,0,0900006480460adb
FDA-2002-P-0226-0004,FDA,FDA-2002-P-0226,"Foods Being Marketed as ""Functional Foods"" [ Issues and Questions from FR Notice] - Testimony",Other,TS-Testimony,2006-12-07T05:00:00Z,2006,12,,,2009-03-18T21:54:57Z,,0,0,09000064804974eb
FDA-2002-P-0226-0006,FDA,FDA-2002-P-0226,Statutory and Regulatory Framework for the Safety of Food Ingredients [FDA/CFSAN]- Testimony,Other,TS-Testimony,2006-12-07T05:00:00Z,2006,12,,,2009-03-18T21:57:55Z,,0,0,09000064804974f3
FDA-2002-P-0226-0005,FDA,FDA-2002-P-0226,Statutory and Regulatory Framework for the Labeling of Food  [FDA/CFSAN]- Testimony,Other,TS-Testimony,2006-12-07T05:00:00Z,2006,12,,,2009-03-18T21:59:34Z,,0,0,09000064804974f1
FDA-2006-P-0280-0002,FDA,FDA-2006-P-0280,"Acknowledgment Letter from FDA DMB to Lachman Consultant Services, Inc.",Other,Acknowledgement Letter/Receipt,2006-12-07T05:00:00Z,2006,12,,,2024-12-10T18:24:01Z,,0,0,09000064804585e2
FDA-2002-P-0226-0003,FDA,FDA-2002-P-0226,"Foods Being Marketed as ""Functional Foods"" [FDA/CFSAN] - Testimony",Other,TS-Testimony,2006-12-07T05:00:00Z,2006,12,,,2009-03-18T22:00:27Z,,0,0,09000064804974e8